Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 134 Records) |
| Query Trace: Neoplasms and C2[original query] |
|---|
| Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution. Frontiers in cell and developmental biology 2021 10 9 722841. Ma Xianxiong, Chen Hengyu, Yang Ming, Ke Zunxiang, Wang Mengyi, Huang Tao, Li L |
| Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma. Journal of oncology 2022 9 2022 5388283. Guo Yang, Liu Ni |
| Dysregulation of Circadian Clock Genes Associated with Tumor Immunity and Prognosis in Patients with Colon Cancer. Computational and mathematical methods in medicine 2022 7 2022 4957996. He Yongshan, Chen Yuanyuan, Dai Xuan, Huang Shiyo |
| Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer. Journal of oncology 2022 7 2022 6567998. Feng Fen, Sun Huake, Zhao Zhikun, Sun Chao, Zhao Yongtian, Lin Hanqing, Yang Jie, Xiao Yajie, Wang Wei, Wu Dongfa |
| Genomic landscape of endometrial carcinomas of no specific molecular profile. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 4 35 (9): 1269-1278. Momeni-Boroujeni Amir, Nguyen Bastien, Vanderbilt Chad M, Ladanyi Marc, Abu-Rustum Nadeem R, Aghajanian Carol, Ellenson Lora H, Weigelt Britta, Soslow Robert |
| Integrative Analysis of Multi-Omics Data-Identified Key Genes With KLRC3 as the Core in a Gene Regulatory Network Related to Immune Phenotypes in Lung Adenocarcinoma. Frontiers in genetics 2022 4 13 810193. Mao Kai, Zhao Yunxi, Ding Bo, Feng Peng, Li Zhenqing, Zhou You Lang, Xue Q |
| Cancer risk and genotype-phenotype correlation in Japanese patients with Cowden syndrome. International journal of clinical oncology 2022 2 27 (4): 639-647. Teramae Satoshi, Muguruma Naoki, Okamoto Koichi, Oseto Kumiko, Nishikawa Ryutaro, Tanoue Takayuki, Hirata Keiji, Yanai Shunichi, Matsumoto Takayuki, Shimizu Seiji, Miwa Jun, Sasaki Yu, Yashima Kazuo, Ohnuma Hiroyuki, Sato Yasushi, Kitayama Yoshitaka, Ohda Yoshio, Yamauchi Atsushi, Sanomura Yoji, Tanaka Kumiko, Kubo Yoshiaki, Ishikawa Hideki, Bando Yoshimi, Sonoda Tomoko, Takayama Tetsu |
| Identification and characterization of three Siglec15-related immune and prognostic subtypes of breast-invasive cancer. International immunopharmacology 2022 Feb 106 108561. Cao Xi, Zhou Yidong, Mao Feng, Lin Yan, Zhou Xingtong, Sun Qia |
| Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance. Nature communications 2022 10 13 (1): 5818. Chakravarthy Ankur, Reddin Ian, Henderson Stephen, Dong Cindy, Kirkwood Nerissa, Jeyakumar Maxmilan, Rodriguez Daniela Rothschild, Martinez Natalia Gonzalez, McDermott Jacqueline, Su Xiaoping, Egawa Nagayasau, Fjeldbo Christina S, Skingen Vilde Eide, Lyng Heidi, Halle Mari Kyllesø, Krakstad Camilla, Soleiman Afschin, Sprung Susanne, Lechner Matt, Ellis Peter J I, Wass Mark, Michaelis Martin, Fiegl Heidi, Salvesen Helga, Thomas Gareth J, Doorbar John, Chester Kerry, Feber Andrew, Fenton Tim |
| Correlation of Tryptophan Metabolic Pathway with Immune Activation and Chemosensitivity in Patients with Lung Adenocarcinoma. Journal of oncology 2022 10 2022 2158525. Wang Zheng, Liu Danni, Yang Rongj |
| Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort. European journal of medical genetics 2022 10 65 (12): 104632. Hendricks Linda A J, Hoogerbrugge Nicoline, Venselaar Hanka, Aretz Stefan, Spier Isabel, Legius Eric, Brems Hilde, de Putter Robin, Claes Kathleen B M, Evans D Gareth, Woodward Emma R, Genuardi Maurizio, Brugnoletti Fulvia, van Ierland Yvette, Dijke Kim, Tham Emma, Tesi Bianca, Schuurs-Hoeijmakers Janneke H M, Branchaud Maud, Salvador Hector, Jahn Arne, Schnaiter Simon, Anastasiadou Violetta Christophidou, Brunet Joan, Oliveira Carla, Roht Laura, Blatnik Ana, Irmejs Arvids, , Mensenkamp Arjen R, Vos Janet |
| Molecular phenotyping of malignant canine mammary tumours: Detection of high-risk group and its relationship with clinicomolecular characteristics. Veterinary and comparative oncology 2022 Oct . Zamani-Ahmadmahmudi Mohamad, Jajarmi Maziar, Talebipour Saeed |
| Identification of secretory pathway-related genes based on Random Forest algorithm to predict the prognosis and immunotherapy response of hepatocellular carcinoma. The journal of gene medicine 2023 9 e3593. Zanzhi Wang, Pengwei Shi, Peng Huang, Chun Xu, Yaoquan He, Wenxiong L |
| Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations. Frontiers in pharmacology 2023 9 14 1224828. Lijuan Li, Nan Wu, Gaojian Zhuang, Lin Geng, Yu Zeng, Xuan Wang, Shuang Wang, Xianhui Ruan, Xiangqian Zheng, Juntian Liu, Ming G |
| Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma. Journal of clinical medicine 2023 7 12 (14): . Haeyoun Choi, In-Cheol Baek, Soon A Park, Jae-Sung Park, Sin-Soo Jeun, Tai-Gyu Kim, Stephen A |
| Genetic mutations in smoking-associated prostate cancer. The Prostate 2023 7 . Ahmed Elshafei, Mohammed Al-Toubat, Allison H Feibus, Kashyap Koul, Seyed Behzad Jazayeri, Navid Lelani, Valencia Henry, K C Bala |
| Identification of STEAP3-based molecular subtype and risk model in ovarian cancer. Journal of ovarian research 2023 6 16 (1): 126. Zouyu Zhao, Chongfeng Sun, Jishuai Hou, Panpan Yu, Yan Wei, Rui Bai, Ping Ya |
| Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer. Breast cancer research and treatment 2023 5 . M K Bos, S W Lam, G Motta, J C A Helmijr, C M Beaufort, E de Jonge, J W M Martens, E Boven, M P H M Jansen, A Jager, S Sleijf |
| Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis. Frontiers in genetics 2023 4 14 1097179. Yuda Lin, Tengfei Li, Zhuolun Li, Chong Shen, Zhouliang Wu, Zhe Zhang, Zhi Li, Shaobo Yang, Zejin Wang, Peng Li, Chong Fu, Jian Guo, Hailong |
| Polymorphism of genes encoding drug-metabolizing and inflammation-related enzymes for susceptibility to cholangiocarcinoma in Thailand. World journal of gastrointestinal pathophysiology 2023 4 14 (2): 21-33. You Gyokukou, Zeng Lu, Tanaka Hideaki, Ohta Emi, Fujii Takahiro, Ohshima Kazuhiko, Tanaka Masakazu, Hamajima Nobuyuki, Viwatthanasittiphong Chutiwan, Muangphot Mantana, Chenvidhya Dhiraphol, Jedpiyawongse Adisorn, Sripa Banchob, Miwa Masanao, Honjo Satos |
| A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target. Journal of clinical medicine 2023 2 12 (4): . Li Han, Tang Ying, Hua Lichun, Wang Zemin, Du Guoping, Wang Shuai, Lu Shifeng, Li W |
| Identification of seven hypoxia-related genes signature and risk score models for predicting prognosis for ovarian cancer. Functional & integrative genomics 2023 1 23 (1): 39. Huang Yan, Zhou Yuqi, Zhang Meiq |
| A disulfidptosis-related classification and risk signature identifies immunotherapy biomarkers and predicts prognosis in gastric cancer: An observational study. Medicine 2024 9 103 (22): e38398. Ruyue Chen, Lixin Jia |
| Identification of clear cell renal cell carcinoma subtypes by integrating radiomics and transcriptomics. Heliyon 2024 6 10 (11): e31816. Ruizhi Gao, Jinshu Pang, Peng Lin, Rong Wen, Dongyue Wen, Yiqiong Liang, Zhen Ma, Li Liang, Yun He, Hong Ya |
| The N6-methyladenosine methylation landscape stratifies breast cancer into two subtypes with distinct immunological characteristics. Clinical and experimental pharmacology & physiology 2024 5 51 (7): e13875. Yang Chen, Yijiang Hou, Shuguang Li, Wenxing Qin, Jian Zha |
| Identification and validation of a novel anoikis-related prognostic model for prostate cancer. Molecular genetics & genomic medicine 2024 4 12 (4): e2419. Peipei Zhang, Wenzhi Lv, Yang Luan, Wei Cai, Xiangde Min, Zhaoyan Fe |
| Immune Subtypes and Characteristics of Endometrial Cancer Based on Immunogenes. Cancer management and research 2024 11 16 1525-1543. Chong Zhang, Jianqing Xu, Ming Wang, Yue He, Yumei |
| Comprehensive analysis of ferroptosis-related genes indicates that TRIM46 is a novel biomarker and promotes the progression of ovarian cancer via modulating ferroptosis and Wnt signaling pathway. American journal of cancer research 2024 11 14 (10): 4686-4707. Shuang Liu, Chunmei Xiao, Yue Rong, Mingbo Liu, Ke Yang, Jing Tang, Zhigang Wa |
| Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis. Scientific reports 2024 10 14 (1): 24203. Yongfeng Wang, Yanzong Zhao, Guangming Zhang, Yifeng Lin, Chunling Fan, Hui Wei, Shude Chen, Ling Guan, Kan Liu, Shenhan Yu, Liangyin Fu, Jing Zhang, Yuan Yuan, Jin He, Hui C |
| Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter study. EBioMedicine 2025 1 112 105548. Jiaolin Zhou, Lifeng Li, Yuxin Liu, Wenzhuo Jia, Qian Liu, Xuan Gao, Aiwen Wu, Bin Wu, Zhanlong Shen, Zhenjun Wang, Jiagang Han, Beizhan Niu, Yuhua Gong, Yanfang Guan, Jianfeng Zhou, Huadan Xue, Weixun Zhou, Ke Hu, Junyang Lu, Lai Xu, Xuefeng Xia, Xin Yi, Ling Yang, Guole L |
- Page last reviewed:Feb 1, 2024
- Content source: